Cumberland Pharmaceuticals (CPIX) Competitors

Assembly Biosciences (NASDAQ:ASMB) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

Does the media favor ASMB or CPIX?

In the previous week, Cumberland Pharmaceuticals had 15 more articles in the media than Assembly Biosciences. MarketBeat recorded 21 mentions for Cumberland Pharmaceuticals and 6 mentions for Assembly Biosciences. Assembly Biosciences' average media sentiment score of 0.24 beat Cumberland Pharmaceuticals' score of -0.20 indicating that Assembly Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Assembly Biosciences	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cumberland Pharmaceuticals	2 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	6 Negative mention(s)	2 Very Negative mention(s)	Neutral

Which has higher earnings & valuation, ASMB or CPIX?

Cumberland Pharmaceuticals has higher revenue and earnings than Assembly Biosciences. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Assembly Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assembly Biosciences	$28.52M	5.02	-$40.18M	-$6.23	-3.01
Cumberland Pharmaceuticals	$37.87M	1.19	-$6.48M	-$0.25	-12.00

Do analysts prefer ASMB or CPIX?

Assembly Biosciences currently has a consensus target price of $33.00, indicating a potential upside of 76.00%. Given Assembly Biosciences' stronger consensus rating and higher probable upside, equities analysts plainly believe Assembly Biosciences is more favorable than Cumberland Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assembly Biosciences	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Cumberland Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has more volatility & risk, ASMB or CPIX?

Assembly Biosciences has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, Cumberland Pharmaceuticals has a beta of -0.39, meaning that its stock price is 139% less volatile than the S&P 500.

Is ASMB or CPIX more profitable?

Cumberland Pharmaceuticals has a net margin of -7.98% compared to Assembly Biosciences' net margin of -124.15%. Cumberland Pharmaceuticals' return on equity of 6.92% beat Assembly Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Assembly Biosciences	-124.15%	-131.77%	-36.81%
Cumberland Pharmaceuticals	-7.98%	6.92%	2.33%

Do institutionals & insiders believe in ASMB or CPIX?

19.9% of Assembly Biosciences shares are held by institutional investors. Comparatively, 15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. 5.3% of Assembly Biosciences shares are held by insiders. Comparatively, 44.9% of Cumberland Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Assembly Biosciences and Cumberland Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks.